SANA
Sana Biotechnology, Inc.
Key Financials
Net Income
$-244166000
↑ 8.5%
Operating Income
$-250319000
↑ 8.2%
Total Liabilities
$256.0M
↑ 2.2%
Shareholders' Equity
$160.9M
↓ 35.8%
EPS (Diluted)
$-0.96
↑ 17.2%
Cash & Equivalents
$71.9M
↓ 43.7%
Total Assets
$416.9M
↓ 16.8%
Operating Cash Flow
$-143828000.00
↑ 35.5%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/15/2026 | View on SEC |
| S-8 | 5/11/2026 | View on SEC |
| 10-Q | 5/11/2026 | View on SEC |
| 8-K | 5/11/2026 | View on SEC |
| ARS | 4/24/2026 | View on SEC |
| DEFA14A | 4/24/2026 | View on SEC |
| DEF 14A | 4/24/2026 | View on SEC |
| 8-K | 4/24/2026 | View on SEC |
| 424B5 | 4/13/2026 | View on SEC |
| 8-K | 4/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | SANA |
| Company Name | Sana Biotechnology, Inc. |
| CIK | 1770121 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (206) 701-7914 |